Skip to main content
M
Doctor-Reviewed Content Verified Hospital Data Updated Medical Information Patient-First Guidance Not for Emergencies — Call 911

Breast Augmentation — Cost, Top Hospitals & Success Rates | MyMedicPlus

Updated: 2026-07-07
Ad — after-intro

Quick Facts

Procedure Type
Cosmetic / Reconstructive Surgery
Duration
1–2 hours
Hospital Stay
Day surgery or 1 night
Recovery
2–6 weeks (full activity at 6–8 weeks)
Cost ( India)
USD 1,500–3,500
Cost ( U S A)
USD 6,000–15,000

What Is Breast Augmentation?

Breast augmentation (augmentation mammoplasty) is a surgical procedure that uses breast implants or fat transfer to increase breast volume, improve breast shape, restore post-pregnancy or post-weight-loss volume loss, or achieve symmetry between unequal breasts. It is consistently among the top five most performed cosmetic surgical procedures worldwide, with over 1.5 million procedures performed annually.

The procedure involves placing saline or silicone gel implants either beneath the breast tissue (subglandular), beneath the pectoral muscle (submuscular/dual-plane), or in a combined plane. Fat transfer (autologous fat grafting) is an implant-free alternative for modest size increases of up to one cup size. Implant selection — size, shape (round vs. anatomical/teardrop), profile (low, moderate, high), and surface (smooth vs. textured) — is guided by patient anatomy, body proportions, and surgical objectives.

Modern breast augmentation at accredited centres carries a strong safety profile when performed by board-certified plastic surgeons. However, implants are not lifetime devices — approximately 20% of patients require revision surgery within 10 years for complications or aesthetic reasons. All patients must be counselled on implant longevity, rupture risk, BIA-ALCL (breast implant-associated anaplastic large cell lymphoma — a rare but serious condition associated with textured implants), and the need for ongoing radiological surveillance.

Indications for Breast Augmentation

Breast augmentation addresses both cosmetic and reconstructive indications:

Hypomastia (Small Breast Volume): The most common indication — women who are dissatisfied with naturally small breast size relative to their body proportions.

Post-Pregnancy and Breastfeeding Volume Loss: Involution after breastfeeding commonly causes significant breast deflation, loss of upper pole fullness, and ptosis (drooping). Augmentation restores pre-pregnancy volume.

Weight Loss-Related Changes: Significant weight loss reduces breast volume and can cause deflation. Augmentation restores fullness.

Breast Asymmetry: Natural or post-surgical breast asymmetry — different implant sizes or fat volumes can correct meaningful size differences (typically >1 cup size difference).

Post-Mastectomy Reconstruction: In combination with tissue expanders and eventual implant exchange, implant-based reconstruction rebuilds the breast after cancer surgery (distinct from purely cosmetic augmentation).

Tubular Breast Deformity: A developmental breast abnormality characterized by constricted, tubular shape and herniation into the areola; requires specific implant sizing and capsule scoring.

Poland Syndrome: Unilateral chest wall underdevelopment requiring asymmetric augmentation for balance.

Gender-Affirming Surgery: Breast augmentation is a core procedure for transgender women seeking feminine chest appearance.

Eligibility, Contraindications & Pre-Operative Assessment

Who Is Eligible: - Age 18+ for saline implants; age 22+ for silicone gel implants (FDA recommendation) - Physically healthy with realistic expectations - Non-smoking or willing to quit 4–6 weeks pre- and post-surgery (smoking significantly increases infection and wound healing risk) - Completed breast development - Body weight within 10–15% of ideal range

Pre-Operative Evaluation: - Comprehensive medical history and physical examination - Breast measurements: base width, ptosis assessment, skin stretch, nipple-to-fold distance - Mammogram (women 35+ or with family history of breast cancer) - Blood tests: CBC, coagulation profile, chemistry panel - Psychological assessment for body dysmorphic disorder (BDD) screening - Discussion of implant type, size, profile, position, and incision location - 3D digital imaging (Vectra, Crisalix) for virtual outcome visualization

Contraindications: - Active breast cancer or unresolved suspicious mammogram findings - Active infection anywhere in the body - Autoimmune disease with active systemic involvement - Unrealistic expectations or evidence of body dysmorphic disorder - Pregnancy or breastfeeding - Bleeding disorders or ongoing anticoagulation

Treatment Options & Techniques

Breast augmentation offers several technique and implant combinations tailored to individual anatomy and aesthetic goals:

Implant Type: - Silicone gel implants: Most commonly used. Cohesive gel maintains shape even if the shell breaks. Available in standard, form-stable ('gummy bear'), and highly cohesive variants. FDA-approved; recommended MRI every 3 years for rupture surveillance. - Saline implants: Filled with sterile saline after insertion — allows smaller incision. Rupture is immediately apparent (deflation). Natural saline absorption if ruptured. - Structured saline (IDEAL IMPLANT): Internal baffles give a more natural feel than standard saline. - Fat transfer (lipofilling): Liposuction harvests autologous fat from abdomen, thighs, or flanks, which is processed and injected into the breast. No implant, no foreign material — but limited to modest size increase and requires sufficient donor fat.

Incision Placement: - Inframammary fold (IMF): most common, provides best access and control; scar hidden under breast crease - Periareolar: around lower areola margin; may affect nipple sensation - Transaxillary (armpit): no breast scar; endoscope-assisted - Transumbilical (TUBA): least common; saline implants only

Implant Pocket Plane: - Subglandular: above pectoralis muscle; shorter recovery, more visible rippling in thin patients - Submuscular (total/partial): under pectoralis; reduces rippling, better mammography window; longer recovery - Dual-plane: upper pole submuscular, lower pole subglandular — most common in modern practice

Benefits & Outcomes

Breast augmentation demonstrates high satisfaction rates supported by outcome data:

Patient Satisfaction: Long-term studies (CORE and MENTOR trials) report satisfaction rates of 95–97% at 5–10 years post-surgery, making it one of the highest-satisfaction cosmetic procedures.

Psychological Benefits: Multiple studies document significant improvements in body image satisfaction, self-confidence, and sexual wellbeing after breast augmentation. A 2022 systematic review of 30+ studies confirmed improvements in quality of life, body satisfaction, and psychosocial wellbeing.

Symmetry Correction: Augmentation effectively addresses asymmetry, with excellent surgeon-reported outcomes for achieving symmetry in 85–90% of asymmetric cases.

Clothing Fit and Appearance: 94% of patients report improved clothing fit and satisfaction with physical appearance post-surgery.

Post-Mastectomy Reconstruction: Two-stage implant reconstruction achieves high patient satisfaction (85–92%) with natural-appearing results when combined with acellular dermal matrix (ADM) and appropriate implant selection.

Durability: Modern cohesive silicone implants have 10-year rupture rates of approximately 7–10% (CORE trial data). Many patients retain original implants for 15–25 years without complication.

Risks & Complications

Breast augmentation carries specific risks that patients must understand:

Capsular Contracture: The most common complication — scar tissue forming around the implant tightens and hardens, causing firmness, pain, and shape distortion. Grade III-IV contracture requiring surgical correction occurs in 5–15% of primary augmentation patients at 10 years.

Implant Rupture: Silicone gel rupture rates are approximately 5–8% at 10 years (FDA data). Silent rupture (no symptoms) is detected by MRI. Saline rupture is immediately apparent as deflation.

BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma): A rare lymphoma associated specifically with textured implants — lifetime risk approximately 1:2,000–1:86,000 for textured implants. Not associated with smooth-surface implants. Presents as late seroma (fluid collection), typically 7–10 years post-implant. Treatable with surgery in 93% of cases.

Breast Implant Illness (BII): A constellation of systemic symptoms (fatigue, joint pain, cognitive difficulties, hair loss) reported by some patients. Causal relationship debated; 2019 FDA review confirmed association. Explantation resolves symptoms in many affected patients.

Infection: Acute surgical infection occurs in 1–2% of cases; chronic low-grade infection can cause capsular contracture.

Changes in Nipple Sensation: Temporary or permanent hypersensitivity or numbness in 5–15% of patients.

Need for Reoperation: Cumulative reoperation rates are 20–25% at 10 years, typically for contracture, rupture, or patient preference changes.

Follow-Up Care & Monitoring

Post-operative follow-up after breast augmentation is structured and lifelong:

Immediate Post-Op (Days 1–7): Drain removal if drains placed. Wound check at 5–7 days. Supportive surgical bra worn 24 hours/day for 4–6 weeks. Activity restrictions: no upper body lifting >2.5 kg for 4–6 weeks, no submersion in water for 2–3 weeks.

6-Week Review: Assessment of wound healing, implant position, pocket development, and early capsule formation. Resolution of post-operative swelling — final aesthetic result not fully apparent until 3–6 months when swelling resolves and implants settle ('drop and fluff').

3-Month and 12-Month Review: Formal assessment of symmetry, implant position, capsule firmness (Baker grading of capsular contracture: Grade I–IV), and patient satisfaction. Massage instructions for capsule prevention reviewed.

Long-Term Silicone Implant Surveillance: FDA recommends MRI at 3 years post-implant and every 2 years thereafter to detect silent rupture. Ultrasound is an acceptable alternative at some centres.

Reoperation Awareness: Patients should understand that implant exchange or removal may be needed for rupture, capsular contracture (Grade III–IV), implant malposition, size change, or BIA-ALCL (occurs in approximately 1 in 2,000–86,000 patients with textured implants; presents as seroma >1 year post-surgery requiring urgent evaluation).

Breast Augmentation Cost by Country

Breast augmentation is among the most popular procedures for medical tourism due to significant international cost differences:

India: USD 1,500–3,500 for complete procedure including surgeon, anesthesia, hospital, and implants (silicone). Leading cosmetic surgery hospitals in Mumbai, Delhi, and Bangalore offer JCI or NABH-accredited facilities with board-certified plastic surgeons.

Thailand: USD 2,500–5,000 at renowned cosmetic surgery hospitals like KTOP clinic, Bumrungrad, or Bangpakok 9. Thailand is one of the world's most popular medical tourism destinations for breast augmentation.

Turkey: USD 2,000–4,500, particularly in Istanbul. Turkey has a highly competitive cosmetic surgery market with European-trained surgeons and excellent facilities.

Mexico: USD 2,500–5,500 at cosmetic surgery centers in Tijuana, Cancun, or Mexico City, popular with US patients due to proximity.

Singapore: USD 6,000–15,000 at premium private hospitals; highest quality in Asia but closest to US pricing.

United States: USD 6,000–15,000+ (all-inclusive, but varies significantly by implant type, surgeon experience, and location).

United Kingdom: GBP 4,500–8,000 ($5,700–10,000) for complete procedure at private cosmetic surgery clinics.

Medical tourists save 50–80% by having breast augmentation in India, Thailand, or Turkey versus US prices, with comparable safety at accredited facilities.

Alternatives & Non-Surgical Options

For patients seeking breast enhancement without implants, or who are reconsidering implant surgery:

Autologous Fat Transfer (Lipofilling): The primary implant-free alternative. Liposuctioned fat is centrifuged and injected into the breast in multiple small aliquots. Advantages: no foreign material, simultaneous body contouring, natural feel and appearance. Limitations: modest size increase only (typically 0.5–1 cup size), up to 30–50% fat reabsorption, multiple sessions may be needed, requires sufficient donor fat, and fat necrosis causing calcifications can interfere with mammography.

External Tissue Expanders (BRAVA System): Non-surgical suction device worn over the breasts for 10–12 hours daily for several weeks before fat transfer to expand the tissue bed and improve fat take rates. Time-consuming and compliance-demanding; results variable.

Padded Bras and External Breast Enhancers: Non-invasive temporary solutions for modest enhancement without surgical risk or recovery.

Breast Lift (Mastopexy): For patients whose primary concern is sagging (ptosis) rather than size — mastopexy repositions the breast and nipple-areola complex without adding volume. Can be combined with modest implant placement if additional volume is desired.

Body Contouring for Improved Proportions: In patients where the perceived small breast size is partly a perception issue related to overall body proportions, abdominal or thigh contouring can improve the breast-waist-hip ratio without breast surgery.

Frequently Asked Questions

Breast implants are not lifetime devices, but many patients retain original implants for 15–25 years without complications. The FDA previously recommended elective replacement at 10 years, but current guidance no longer endorses routine replacement without clinical indication. You should consider replacement if: the implant ruptures, capsular contracture develops, significant bottoming-out or malposition occurs, or your aesthetic goals change. MRI screening every 5–6 years after the initial 3-year scan is recommended for silicone implants to detect silent rupture. Many patients with no complications choose to never replace their original implants.
Recovery from breast augmentation typically follows this timeline: first 24–48 hours — moderate soreness, prescribed pain medication, drain management if applicable; week 1 — light activity, no lifting over 5 lbs; weeks 2–3 — return to desk work and light daily activities; week 4–6 — return to driving and moderate exercise; week 6–8 — full exercise including upper body training. Submuscular placement typically involves more soreness for the first 1–2 weeks compared to subglandular placement. Final implant settling and shape stabilization takes 3–6 months as swelling resolves and implants 'drop and fluff' into their final position.
Most women who have breast augmentation retain the ability to breastfeed. The ability to breastfeed is primarily determined by glandular tissue and nipple-areola complex preservation. Periareolar incisions carry a slightly higher risk of reduced nipple sensation and potential impact on breastfeeding compared to inframammary incisions. Subglandular placement has slightly more potential to compress ductal tissue than submuscular placement. Studies show breastfeeding success rates of 60–70% in post-augmentation patients compared to 70–80% in non-augmented controls. If preserving breastfeeding ability is a priority, discuss incision location and implant positioning choices with your surgeon.
Silicone gel implants contain a cohesive silicone gel filling that closely mimics natural breast tissue feel — softer, more natural texture, less rippling. They are the most commonly chosen option (90%+ of augmentation cases) and are approved for use from age 22. Saline implants contain sterile saltwater and can be filled at surgery, allowing adjustment. They are firmer, more prone to visible rippling (especially in thin patients), but if rupture occurs, saline is safely absorbed. They are approved from age 18 and tend to cost less. In thin patients with little natural tissue, silicone implants generally produce more natural-looking results. 'Gummy bear' (form-stable, highly cohesive silicone) implants maintain shape even when cut in half.

References

  1. Spear SL, et al. Silicone gel breast implant core study results at 6 years. Plast Reconstr Surg. 2007.
  2. U.S. FDA. Breast Implants — Certain Labeling Recommendations. FDA Safety Communication, 2020.
  3. U.S. FDA. Breast Implant-Associated Anaplastic Large Cell Lymphoma. FDA Update, 2022.
  4. Stevens WG, et al. Risk factor analysis for capsular contracture in primary augmentation. Aesthet Surg J. 2013.
Ad — after-content

Medically Reviewed

Our medical content follows strict editorial guidelines to ensure accuracy and reliability.

Up to Date

Last updated: 2026-07-07

Important: This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.

Ready to take the next step?

Connect with top hospitals and specialists. Get personalized guidance for your medical journey.

Latest from our blog and forum

Latest from Our Blog

View All →

Latest Forum Discussions

View All →
Compare Costs Get Free Help

Medical Disclaimer: The information on MyMedicPlus is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site.